ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice.

Kelliher, M A; Weckstein, D J; Knott, A G; Wortis, H H; Rosenberg, N

Kelliher, M A; Weckstein, D J; Knott, A G; Wortis, H H; Rosenberg, N.

Affiliation

Kelliher MA; Department of Pathology, Tufts University School of Medicine, Boston, Massachussetts 02111.

Oncogene ; 8(5): 1249-56, 1993 May.

Article in En | MEDLINE | ID: mdl-8479746

Subject(s)

Bone Marrow/pathology; Cell Transformation, Neoplastic; Fluorouracil/pharmacology; Genes, abl; Hematopoietic Stem Cells/pathology; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/etiology; Lymphoma/etiology; Animals; Base Sequence; Bone Marrow/immunology; Bone Marrow/microbiology; Fusion Proteins, bcr-abl/genetics; Interleukin-3/pharmacology; Macrophage-1 Antigen/analysis; Mice; Molecular Sequence Data; Phenotype; Proviruses/isolation & purification

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow / Hematopoietic Stem Cells / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Cell Transformation, Neoplastic / Genes, abl / Fluorouracil / Lymphoma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 1993 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links